Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Human evidence - Phase 3 TRIUMPH-1 (Eli Lilly, May 21, 2026) 2,339 adults with obesity or overweight without diabetes
The active ingredient in semaglutide GLP-1 injections is a type of GLP-1 receptor agonist
Every batch of CJC-1295 No DAC (10mg) + Ipamorelin (10mg) Blend is tested for purity and identity using industry-standard methods
This emerging option has shown potential benefits not only for weight management but also for areas such as metabolic health, insulin regulation, and long-term wellness
Mechanism of Action
US$ 20.35
US$ 27.17
US$ 28.09
